ACTL6A promotes metastasis and cell proliferation in hepatocellular carcinoma and head and neck SCC and plays a pivotal role in tumor progression and patient survival outcomes by activating the Notch and Hippo–YAP pathways [22, 24]. This evidence concerns the gene ACTL6A and hepatocellular carcinoma.